NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

